Literature DB >> 32798592

Influence of polymer addition on the amorphization, dissolution and physical stability of co-amorphous systems.

Jingwen Liu1, Holger Grohganz2, Thomas Rades1.   

Abstract

Co-amorphous systems have been developed to address the solubility challenge of poorly-water soluble drugs. However, the dissolution rate of co-amorphous systems can be too fast in some cases, causing super-saturation, followed by precipitation and thereafter loss of the advantage. In this study, hydroxypropyl methylcellulose (HPMC) was co-formulated at 10% (w/w) with carvedilol-L-aspartic acid (CAR-ASP) co-amorphous systems at CAR to ASP molar ratios of 1:1, 1:1.5 and 1:2. No obvious changes of glass transition temperatures (Tgs) were detected for CAR-ASP 1:1.5-HPMC and CAR-ASP 1:2-HPMC compared to the corresponding co-amorphous systems, whilst CAR-ASP 1:1-HPMC showed an increased Tg (88.9 ± 1.3 °C) compared to CAR-ASP 1:1 (80.2 ± 0.9 °C). HPMC was involved in the molecular interactions of the CAR-ASP-HPMC systems, but did not disturb ionic interactions between CAR and ASP. Addition of HPMC optimized the dissolution of the CAR-ASP systems by reducing the initial dissolution rate and maintaining super-saturation for a longer period. No negative effect of HPMC addition on physical stability was observed at 25 °C and 40 °C under dry conditions for 7 months. Therefore, it appears promising to co-formulate a small amount of polymer with co-amorphous systems to achieve optimized dissolution characteristics while maintaining the desired physical stability.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amorphization; Co-amorphous; Dissolution; Molecular interaction; Physical stability; Polymer

Mesh:

Substances:

Year:  2020        PMID: 32798592     DOI: 10.1016/j.ijpharm.2020.119768

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.

Authors:  Qin Shi; Yanan Wang; Sakib M Moinuddin; Xiaodong Feng; Fakhrul Ahsan
Journal:  AAPS PharmSciTech       Date:  2022-09-19       Impact factor: 4.026

2.  Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug-Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug.

Authors:  Li Ming Lim; Jin-Won Park; Kunn Hadinoto
Journal:  Pharmaceutics       Date:  2022-05-02       Impact factor: 6.525

3.  Prediction and Preparation of Coamorphous Phases of a Bislactam.

Authors:  Luke I Chambers; Osama M Musa; Jonathan W Steed
Journal:  Mol Pharm       Date:  2022-06-22       Impact factor: 5.364

4.  Characterization, Stability, and Antibrowning Effects of Oxyresveratrol Cyclodextrin Complexes Combined Use of Hydroxypropyl Methylcellulose.

Authors:  Jianfei He; Huai-Yu Chen; Hongbin Chen; Baobei Wang; Fengxian Guo; Zong-Ping Zheng
Journal:  Foods       Date:  2022-08-16

5.  The Effect of Various Poly (N-vinylpyrrolidone) (PVP) Polymers on the Crystallization of Flutamide.

Authors:  Dawid Heczko; Barbara Hachuła; Paulina Maksym; Kamil Kamiński; Andrzej Zięba; Luiza Orszulak; Marian Paluch; Ewa Kamińska
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-06

Review 6.  Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies.

Authors:  Jingwen Liu; Holger Grohganz; Korbinian Löbmann; Thomas Rades; Nele-Johanna Hempel
Journal:  Pharmaceutics       Date:  2021-03-15       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.